Mayo Clinic offers at-home colon cancer test

August 26, 2014 by Paul Walsh, Star Tribune (Minneapolis)

Mayo Clinic is taking another step toward making detection of colorectal cancer as convenient as possible, announcing Monday an at-home kit that arrives and is sent back in the mail, stool sample included.

In a joint announcement with Cologuard kit maker Exact Sciences of Madison, Wis., Mayo said the screening test will be available through its primary care doctors by prescription only.

Patients learn of their results in as little as two weeks from their doctor. A positive result prompts the need for a colonoscopy.

"Cologuard represents a significant advancement in identifying at its most treatable stage," Dr. Vijay Shah, chairman of gastroenterology and hepatology for Mayo, said in a statement accompanying the announcement. "We believe offering this new tool will promote patient and community public health and may move more patients to get screened earlier - a critical step in beating this prevalent and preventable cancer."

Cologuard was developed jointly by Mayo and Exact Sciences as the first - and so far, the only - noninvasive stool DNA screening test for colorectal cancer that has approval from the Food and Drug Administration.

The tests are meant for people 50 and older who are at average risk for colorectal cancer. Exact Science said it is the first noninvasive screening that analyzes both stool-based DNA and blood biomarkers to detect cancer and precancer.

With proper , colorectal cancer is highly preventable. However, 23 million Americans ages 50 to 75 are not getting screened as recommended, a factor in colorectal cancer remaining the second-leading cancer killer in the United States. Early detection can mean a five-year survival rate of more than 90 percent.

Dr. David Ahlquist, a Mayo gastroenterologist and co-inventor of the test, said, "I am hopeful that the test's efficacy and convenience will result in improved detection and survival rates for colorectal ."

Explore further: Noninvasive colorectal cancer screening tool shows unprecedented detection rates

Related Stories

Noninvasive colorectal cancer screening tool shows unprecedented detection rates

March 19, 2014
Results of a clinical trial of Cologuard show unprecedented rates of precancer and cancer detection by a noninvasive test. The detection rates are similar to those reported for colonoscopy. The results were published in the ...

FDA approves first DNA-based test for colon cancer (Update)

August 11, 2014
The Food and Drug Administration on Monday approved the first screening test for colon cancer that uses patients' DNA to help spot potentially deadly tumors and growths.

Flexible sigmoidoscopy screening reduces colorectal cancer incidence, rate of death

August 12, 2014
Among about 100,000 study participants, screening with flexible sigmoidoscopy resulted in a reduced incidence and rate of death of colorectal cancer, compared to no screening, according to a study in the August 13 issue of ...

Noninvasive stool test for colorectal cancer unaffected by variables

April 3, 2012
A study presented today by Mayo Clinic researchers at the American Association for Cancer Research (AACR) Annual Meeting 2012 in Chicago identified two genes that are optimal targets to be analyzed in a new noninvasive test ...

New test offers greater accuracy in early detection of colorectal cancer

January 19, 2012
Results of two studies suggest that a new, investigational colorectal cancer screening test developed in a collaboration between Mayo Clinic and Exact Sciences Inc. of Madison, Wis., is highly accurate and significantly more ...

FDA advisers back Exact Sciences colon cancer test

March 27, 2014
A panel of Food and Drug Administration advisers has voted to endorse an experimental stool test that uses DNA to detect colon cancer and precancerous growths.

Recommended for you

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.